The DOI matches its Crossref record; 148 of the 149 references it cites were found in a registry or an index.
Big data in IBD: a look into the future
Open accessAbstract
Big data methodologies, made possible with the increasing generation and availability of digital data and enhanced analytical capabilities, have produced new insights to improve outcomes in many disciplines. Application of big data in the health-care sector is in its early stages, although the potential for leveraging underutilized data to gain a better understanding of disease and improve quality of care is enormous. Owing to the intrinsic characteristics of inflammatory bowel disease (IBD) and the management dilemmas that it imposes, the implementation of big data research strategies not only can complement current research efforts but also could represent the only way to disentangle the complexity of the disease. In this Review, we explore important potential applications of big data in IBD research, including predictive models of disease course and response to therapy, characterization of disease heterogeneity, drug safety and development, precision medicine and cost-effectiveness of care. We also discuss the strengths and limitations of potential data sources that big data analytics could draw from in the field of IBD, including electronic health records, clinical trial data, e-health applications and genomic, transcriptomic, proteomic, metabolomic and microbiomic data. In this Review, the authors explore potential applications of big data in IBD research, including predictive models of disease course and response to therapy, characterization of disease heterogeneity, drug safety and development, precision medicine and cost-effectiveness of care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, Rath et al. employed molecular imaging to detect α4β7 integrin expression in a cohort of 5 CD patients before vedolizumab therapy.81”
From Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease (2024) · cites this paper as [81]
In the citing paper
“Their findings revealed that responders to treatment had peri cryptal α4β7+ cells, whereas non-responders did not have any α4β7+ cells.”
From Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease (2024) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
(2011) · Cited by 5,203
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
The Danish National Patient Registry: a review of content, data quality, and research potential
Schmidt, M., Schmidt, S. A. J., Sandegaard, J. L., Ehrenstein, V., Pedersen, L. H., & Sørensen, H. T. (2015) · Clinical Epidemiology · doi:10.2147/clep.s91125 · Cited by 4,832
Detecting influenza epidemics using search engine query data
Ginsberg, J., Mohebbi, M. H., Patel, R. S., Brammer, L., Smolinski, M. S., & Brilliant, L. (2009) · Nature · doi:10.1038/nature07634 · Cited by 4,295
Ungaro, R. C., Mehandru, S., Allen, P. B., Peyrin‐Biroulet, L., & Colombel, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,659
Self-citationPredicting the future - big data, machine learning, and clinical medicine
Obermeyer, Z., & Emanuel, E. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1606181 · Cited by 3,652
Data-intensive applications, challenges, techniques and technologies: A survey on Big Data
Philip Chen, C. L., & Zhang, C.-Y. (2014) · Information Sciences · doi:10.1016/j.ins.2014.01.015 · Cited by 3,047
Big data analytics in healthcare: promise and potential
Raghupathi, W., & Raghupathi, V. (2014) · Health Information Science and Systems · doi:10.1186/2047-2501-2-3 · Cited by 3,034
Research works printed but not linked: 3
- Celgene. Celgene provides update on GED-0301 (mongersen) inflammatory bowel disease program. Celgene https://ir.celgene.com/press-releases/press-release-details/2017/Celgene-Provides-Update-on-GED-0301-mongersen-Inflammatory-Bowel-Disease-Program/default.aspx (2017).
- Boelle, P.-Y., Thiébaut, R. & Costagliola, D. Données massives, vous avez dit données massives? Quest. Santé Publique 30, 1–4 (2015).
- Mirkov, M. U., Verstockt, B. & Cleynen, I. Genetics of inflammatory bowel disease: beyond NOD2. Lancet Gastroenterol. Hepatol. 2, 224–234 (2017).
Cited by
Sorted by citations
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Qiu, S., Cai, Y., Yao, H., Lin, C., Xie, Y., Tang, S., & Zhang, A. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01399-3 · Cited by 993
Gut microbiome, big data and machine learning to promote precision medicine for cancer
Cammarota, G., Ianiro, G., Ahern, A., Carbone, C., Temko, A., Claesson, M. J., Gasbarrini, A., & Tortora, G. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0327-3 · Cited by 324
Artificial intelligence in gastroenterology: A state-of-the-art review
Kröner, P. T., Engels, M. M. L., Glicksberg, B. S., Johnson, K. W., Mzaik, O., van Hooft, J. E., Wallace, M. B., El‐Serag, H. B., & Krittanawong, C. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i40.6794 · Cited by 175
Liang, L., Yang, C., Liu, L., Mai, G., Li, H., Wu, L., Jin, M., & Chen, Y. (2022) · Microbial Cell Factories · doi:10.1186/s12934-022-01812-6 · Cited by 104
Precision medicine in inflammatory bowel disease: concept, progress and challenges
Borg‐Bartolo, S., Boyapati, R. K., Satsangi, J., & Kalla, R. (2020) · F1000Research · doi:10.12688/f1000research.20928.1 · Cited by 92
Metadata
- Authors
- Olivera, P., Danese, S., Jay, N., Natoli, G., & Peyrin-Biroulet, L.
- Affiliations
- Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (AR)
- IRCCS Humanitas Research Hospital (IT)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2019-01-18
- Volume
- 16
- Issue
- 5
- Pages
- 312-321
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2910890040
- Cited by
- 151
- References
- 149
- Citations by year
- 2026: 4 · 2025: 18 · 2024: 28 · 2023: 14 · 2022: 32 · 2021: 27 · 2020: 18 · 2019: 10
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion, other-oa)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Social Sciences › Decision Sciences › Information Systems and Management › Big Data Technologies and Applications
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Keywords
- big data, inflammatory bowel disease, predictive modeling, disease progression prediction, treatment response prediction, disease heterogeneity, drug safety, drug development, precision medicine, cost-effectiveness, electronic health records, clinical trial data, e-health applications, multi-omics data, microbiome data
- MeSH terms
- Clinical Decision-Making, Big Data, Cost-Benefit Analysis, Humans, Prognosis, United States, Inflammatory Bowel Diseases, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
